The SBIR/STTR Program Went Dark for Six Months. It Just Came Back With $30 Million Awards.

For six months, America's largest source of non-dilutive early-stage funding for technology startups didn't exist. The SBIR and STTR programs — which collectively distribute nearly $6 billion per year across 11 federal agencies — expired on September 30, 2025, and Congress let them lapse. No new solicitations. No new awards. Thousands of small businesses that depend on federal R&D contracts watched their pipeline go dry while legislators negotiated.

On April 13, 2026, President Trump signed the Small Business Innovation and Economic Security Act (S.3971) into law, reauthorizing both programs through September 30, 2031. The Senate had passed it unanimously on March 3. The House followed on March 17, 345-41. Within days of the signing, agencies began reopening solicitations — the Department of Defense released 91 new topics immediately, NASA published its first Broad Agency Announcement in over six months, and NIH announced its program was officially back on April 21.

But S.3971 isn't just a restart. It's a structural overhaul that changes how SBIR/STTR awards work, who can win them, and how much money is on the table. If you're a small business that competes for federal R&D funding, the program you remember from 2025 no longer exists in quite the same form.

The Gap That Almost Killed the Pipeline

The authorization lapse wasn't supposed to happen. Congress had extended SBIR/STTR dozens of times since the program's creation in 1982, usually without drama. But the 2025 expiration collided with a government shutdown that lasted six weeks in late fall, followed by a protracted budget fight that didn't resolve until late January 2026 — nearly four months into the fiscal year.

During the gap, agencies couldn't issue new Phase I or Phase II awards. Companies that had submitted proposals before the expiration waited in limbo. Startups that had timed their cash flow around expected SBIR revenue scrambled for bridge financing or cut staff. The National Science Foundation, already operating at roughly 20% of its normal grant-making pace due to the shutdown backlog, couldn't even begin processing SBIR proposals.

The damage wasn't hypothetical. SBIR and STTR fund over 4,000 small businesses annually. These companies have generated more than 70,000 patents and attracted $41 billion in venture capital over the programs' four-decade history. The Department of Defense alone issues 2,250+ awards per year totaling roughly $3 billion. When that pipeline stops, the effects cascade through the defense industrial base, the biomedical research ecosystem, and the broader innovation economy.

"Small businesses provide key components, technology, and services to prime defense contractors," noted a CSIS analysis of the reauthorization. In an era of heightened geopolitical competition — with active conflicts in Europe and the Middle East and rising tensions in the Indo-Pacific — a six-month pause in funding the companies that feed the defense supply chain wasn't just an administrative inconvenience. It was a national security gap.

Strategic Breakthrough Awards: The Headline Change

The most consequential new feature in S.3971 is the Strategic Breakthrough Allocation — a funding mechanism that didn't exist before and fundamentally changes SBIR's ceiling.

Under the old system, Phase I awards typically ranged from $50,000 to $275,000, and Phase II awards topped out around $600,000 to $2.8 million depending on the agency. The notorious "valley of death" between Phase II development and Phase III commercialization killed promising technologies because companies exhausted their SBIR funding before they could attract production contracts or private capital.

Strategic Breakthrough Awards attack this gap directly. Agencies with annual SBIR obligations exceeding $100 million — primarily the Department of Defense, the Department of Health and Human Services, the Department of Energy, and NASA — can now issue individual awards of up to $30 million over 48 months to companies that have completed at least one Phase II award.

That's not a typo. A single SBIR award can now reach $30 million, structured either as a lump sum or milestone-triggered payments. The award can be a contract rather than a grant, giving agencies more flexibility in directing technical outcomes.

The catch: 100% matching funds. To receive a Strategic Breakthrough Award, a company must secure matching capital equal to the full award amount from new private investment or qualifying non-SBIR government sources. For Defense Department projects specifically, at least 20% of the matching funds must come from new DoD sources, with a senior official committing to include the technology in acquisition plans.

This matching requirement is the filter. It ensures Strategic Breakthrough Awards flow to companies that have already demonstrated commercial viability — not to firms that treat SBIR as a permanent revenue source. Companies that can raise $30 million in matching capital alongside a $30 million federal award are, by definition, building real products with real markets.

Agencies can allocate up to 0.5% of their extramural research budgets to Strategic Breakthrough Awards. For DoD, that translates to roughly $15 million per year. It's modest relative to total SBIR spending, but it creates a pathway that previously didn't exist: a federal mechanism for bridging the gap between prototype and production at genuine scale.

The SBIR Mills Problem Gets a Cap

One of the program's most persistent criticisms is the "SBIR mill" — companies that repeatedly win Phase I and Phase II awards while maintaining small-business status, effectively treating the program as a permanent funding source rather than a launchpad for commercialization. GAO data suggests fewer than 1% of awardees fit this pattern, but the perception has dogged the program for years.

S.3971 addresses it directly. Starting in fiscal year 2027, each participating agency must establish annual caps on Phase I and Phase II proposals per company, per solicitation, or per topic. Agencies have 90 days before the fiscal year begins to publish their proposal limits, with limited waiver authority — no more than 5% of topics annually can receive waivers for mission-critical needs.

The practical effect will vary by agency. DoD, which processes thousands of topics per year, may set relatively generous per-company limits. NSF, which funds fewer but larger awards, may be more restrictive. Companies that currently submit proposals across dozens of topics per cycle should expect to make strategic choices about where to compete — a significant shift for firms accustomed to shotgunning applications.

Enhanced Security Screening: The Foreign Adversary Filter

S.3971 significantly expands national security due diligence requirements. Under the new law, agencies must examine every applicant for foreign affiliations with entities in "countries of concern" — a designation that currently includes China, Russia, Iran, and North Korea. The screening covers investment ties, technology licensing arrangements, cybersecurity practices, employee background checks, and any business relationships that could create technology transfer risks.

Entities appearing on designated federal watchlists face automatic exclusion. Companies with any foreign affiliation will face heightened scrutiny, and the burden of documentation falls on the applicant. If your company has received investment from a firm with Chinese limited partners, licensed technology from a foreign university, or employs researchers who maintain active collaborations with institutions in countries of concern, expect your proposal to receive additional review — and prepare to address those connections explicitly in your submission.

This isn't entirely new. SBIR has had foreign ownership restrictions since its inception, and recent years saw increasing scrutiny of Chinese-affiliated applicants. But S.3971 codifies and standardizes the screening process across all 11 participating agencies, creating a uniform due diligence framework where previously each agency applied its own ad hoc procedures.

What the Agencies Are Doing Right Now

The speed of agency response after signing has been remarkable, if uneven.

Department of Defense moved fastest. On April 13 — the day the bill was signed — DoD released 91 new SBIR/STTR topics across Army, Navy, Air Force, DARPA, the Defense Health Agency, and SOCOM. Release 12 of the FY2026 BAA is open through May 13, with monthly releases resuming on the first Wednesday of each month. DARPA pre-released several topics including ALIAS Missionized Autonomy for Emergency Services (an SBIR XL award) and the Smart Whole Blood Field Transfusion system.

NASA transitioned to a Broad Agency Announcement structure for Phase I and Phase II, releasing its first BAA on April 17. Pilot appendices with SBIR subtopics followed on April 21. NASA is also implementing a new ProSAMS registration system — companies will need to register before submitting proposals, so don't wait until the deadline.

NIH announced program reactivation on April 21, with the next official Phase II deadline set for September 5. Watch for interim deadlines between now and then — NIH historically adds submission windows when recovering from program interruptions.

NSF is the furthest behind, announcing only that it will "resume new Project Pitch submissions in the coming weeks." A new solicitation is expected with a July deadline. Given NSF's broader grant-making delays — the agency has awarded just 613 grants total in FY2026, about 20% of its normal pace — SBIR applicants should expect longer-than-usual processing times.

How to Compete in the New Landscape

The reauthorization creates both urgency and opportunity. Urgency because agencies are rushing to distribute FY2026 funds — S.3971 includes a carryover provision allowing agencies to spend unused FY2026 SBIR/STTR allocations, meaning there's a bolus of pent-up funding entering the pipeline. Opportunity because the first solicitations after a six-month pause will attract fewer fully prepared applicants than a normal cycle.

Several strategic considerations for the months ahead:

Deadlines will be compressed. DoD's first post-reauthorization solicitations gave companies roughly one month between opening and close. This pattern will likely continue across agencies. If you haven't been monitoring topics during the lapse, you're already behind. Set up alerts on DSIP (the DoD SBIR/STTR Innovation Portal), SAM.gov, and agency-specific portals now.

Prepare your foreign-affiliation documentation early. The enhanced security screening means proposal review timelines may be longer, especially for companies with any international connections. Proactively documenting your ownership structure, investor base, and personnel affiliations will prevent delays.

Strategic Breakthrough Awards require groundwork before application. The matching-fund requirement means you can't apply opportunistically — you need committed capital partners. If you're a Phase II graduate with a technology that's approaching commercialization, start investor conversations now. The agencies haven't published their Strategic Breakthrough solicitation procedures yet, but when they do, the companies that move fastest will be those that already have matching commitments lined up.

Expect proposal limits to reshape competition. When agencies publish their annual submission caps before FY2027, companies will need to prioritize their strongest topics rather than submitting broadly. This may benefit first-time applicants who face less competition from established SBIR performers.

The six-month lapse was painful, but the program that emerged from it is more ambitious than what came before. Strategic Breakthrough Awards create a genuine bridge across the valley of death. Enhanced security measures protect the technologies these programs develop. And proposal caps may finally redirect funding toward the commercialization outcomes the program was designed to produce. For small businesses with real technology and real market potential, tools like Granted can help you identify the right solicitations and build competitive proposals before the compressed deadlines close.